Related Experiment Video
Updated: May 30, 2026
08:10
The 6-hydroxydopamine Rat Model of Parkinson's Disease
Published on: October 27, 2021
Parkinson's disease and anaesthesia.
Safiya I Shaikh1, Himanshu Verma
1Department of Anaesthesiology, KIMS, Hubli, Karnataka, India.
Indian Journal of Anaesthesia
|August 3, 2011
Summary
Parkinson's disease (PD) presents unique anesthetic challenges due to patient age and drug interactions. This review details anesthetic management for PD patients undergoing surgery, covering pre-, intra-, and post-operative care.
Area of Science:
- Neurology
- Anesthesiology
Background:
- Parkinson's disease (PD) is a common, disabling neurological disorder affecting 1% of individuals over 60.
- It involves the degeneration of central nervous system dopaminergic pathways in the basal ganglia.
- PD is increasingly prevalent in surgical patients due to an aging population.
Purpose of the Study:
- To review the anesthetic considerations for surgical patients with Parkinson's disease.
- To outline preoperative, intraoperative, and postoperative anesthetic management strategies.
- To briefly discuss intraoperative PD exacerbation and anesthesia for stereotactic pallidotomy.
Main Methods:
- Literature review focusing on anesthetic management in Parkinson's disease patients.
- Analysis of challenges including patient age, drug interactions, and systemic alterations.
- Examination of specific anesthetic techniques and patient care protocols.
Main Results:
- Anesthetic management requires careful consideration of PD-related systemic changes.
- Drug interactions between antiparkinsonian and anesthetic agents are a significant concern.
- Perioperative morbidity in PD patients necessitates tailored anesthetic approaches.
Conclusions:
- Optimized anesthetic care is crucial for reducing perioperative morbidity in Parkinson's disease patients.
- Comprehensive management strategies are needed for preoperative, intraoperative, and postoperative phases.
- Further research into anesthetic techniques for PD patients, including those undergoing specialized procedures like pallidotomy, is warranted.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24General Anesthesia: Overview
Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...